HT
HZNP

HAP Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

HAP Trading’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,012,300
Closed -$2.53M – 1261
2023
Q3 		$2.53M Sell
1,012,300
-59,300
-6% -$6.37M 0.4% 56
2023
Q2 		$708K Buy
+1,071,600
New +$113M 0.12% 150
2023
Q1 		– Sell
-190,800
Closed -$277K – 1811
2022
Q4 		$277K Buy
+190,800
New +$15.8M 0.03% 400
2021
Q2 		– Sell
-647,600
Closed -$2.24M – 2785
2021
Q1 		$2.24M Sell
647,600
-9,800
-1% -$827K 0.12% 159
2020
Q4 		$3.19M Buy
657,400
+636,900
+3,107% +$47.3M 0.09% 191
2020
Q3 		$248K Sell
20,500
-313,100
-94% -$21.5M 0.01% 577
2020
Q2 		$1.55M Buy
+333,600
New +$14.3M 0.09% 209
2018
Q2 		– Sell
-22,400
Closed -$1K – 1214
2018
Q1 		$1K Buy
+22,400
New +$331K ﹤0.01% 897
2017
Q2 		– Sell
-14,000
Closed -$8K – 1257
2017
Q1 		$8K Sell
14,000
-1,195,700
-99% -$19.4M ﹤0.01% 934
2016
Q4 		$148K Buy
1,209,700
+1,183,100
+4,448% +$21.5M 0.01% 508
2016
Q3 		$99K Buy
26,600
+5,300
+25% +$104K ﹤0.01% 593
2016
Q2 		$78K Buy
+21,300
New +$345K ﹤0.01% 544

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

HAP Trading's HZNP Position: Q3 2022 in Review

HAP Trading sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 10,475 shares — an estimated $835K sold.

HAP Trading first reported a position in HZNP in Q1 2014 and held it in 13 quarters. The position peaked at $8.68M in Q4 2020. 529 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.

  • HAP Trading reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • HAP Trading sold 10,475 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $835K.
  • HAP Trading first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 13 quarters.
  • HAP Trading's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $8.68M in Q4 2020.
  • 529 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.

Based on HAP Trading's 13F filing for Q3 2022, filed 14 Nov 2022.